Figure 1 provides an overview of the inflammatory microenvironment (IME) in endometrial cancer, depicting immune-cell infiltration and ECM remodeling, macrophage polarization (M1/M2), canonical checkpoint signaling (PD-1/PD-L1, CTLA-4/CD80), and representative IME-targeted strategies. This evidence concerns the gene PDCD1 and endometrial cancer.